ArticleInternational journal of clinical and experimental pathology2015

FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.

Ruixia Ma et al.PubMed ↗Full text ↗

No numbers read from the abstract.